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Abstract Ultra-high-pressure liquid chromatography
(UHPLC) systems able to work with columns packed
with sub-2 μm particles offer very fast methods to
determine the lipophilicity of new chemical entities. The
careful development of the most suitable experimental
conditions presented here will help medicinal chemists for
high-throughput screening (HTS) log Poct measurements.
The approach was optimized using a well-balanced set of
38 model compounds and a series of 28 basic compounds
such as β-blockers, local anesthetics, piperazines, cloni-
dine, and derivatives. Different organic modifiers and
hybrid stationary phases packed with 1.7-μm particles were
evaluated in isocratic as well as gradient modes, and the
advantages and limitations of tested conditions pointed out.
The UHPLC approach offered a significant enhancement
over the classical HPLC methods, by a factor 50 in the
lipophilicity determination throughput. The hyphenation of
UHPLC with MS detection allowed a further increase in the
throughput. Data and results reported herein prove that the
UHPLC-MS method can represent a progress in the HTS-
measurement of lipophilicity due to its speed (at least a
factor of 500 with respect to HPLC approaches) and to an
extended field of application.
Keywords Lipophilicity . UHPLC .
Reversed-phase liquid chromatography . Partition
coefficients . Physicochemical profiling
Introduction
Precise knowledge of physicochemical properties of new
chemical entities (NCEs) is essential in early steps of
investigations of a new drug [1, 2]. Among these properties,
lipophilicity is a key parameter to understand and somehow
predict pharmacokinetic processes such as absorption, distri-
bution, metabolism, excretion, and toxicity (ADMET), partic-
ularly in terms of membrane permeation. Lipophilicity also
significantly contributes to understand and model ligand–
target interactions underlying the pharmacodynamic phase [3].
Moreover, this parameter appears in many (quantitative)
structure–activity relationships (Q)SAR of various classes of
compounds [4], which further emphasize its importance.
In silico methods are widely used for lipophilicity
estimation despite their lack of accuracy due to the neglect
of the 3D structure effect or to unknown fragments [5]. It is
therefore necessary to build suitable and extended chemical
libraries of experimental lipophilicity data [6, 7].
Different in vitro approaches have been reported to
measure lipophilicity. The classical shake-flask technique
still remains the reference for lipophilicity measurements,
although the procedure is time-consuming, sensitive to
impurities and the measurable log Poct (octanol–water
partition coefficient sometimes called log Po/w) range
restricted to −3 to 3 [8–10]. Several studies using
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potentiometry have been reported but this method is only
appropriate for ionizable solutes [8, 9, 11]. More recently,
microemulsion electrokinetic chromatography (MEEKC)
[12–14] has been proposed for log Poct determination.
This separation technique is characterized by many
advantages, namely low sample consumption, insensitivity
to impurities, potential for automation, high throughput,
and low cost. However, there are several issues to
overcome the lack of electroosomotic flow when working
at low pH values. The LC approach has also been widely
used and recognized as a good alternative to these
methods because it presents some evident benefits (similar
to those observed in MEEKC) [12, 14–19]. However, it is
difficult to handle highly basic or highly lipophilic
compounds, due to the instability of silica-based station-
ary phases in high pH conditions and to long analysis
time, respectively [20]. Centrifugal partition chromatog-
raphy (CPC) has also been scarcely reported for log P
determination but cannot be considered as a high-
throughput method [21–24].
LC lipophilicity measurements can be performed either
in isocratic or gradient mode. In isocratic conditions, the
log kw is obtained by extrapolation to 100% water plotting
isocratic log k values as a function of the mobile phase
composition. The relationship between isocratic log k
values and organic modifier concentration depends on the
experimental conditions. With methanol, isocratic log k
values are generally linearly correlated to the organic
modifier percentage ’ in the mobile phase:
log k ¼ log kw  S  ϕ ð1Þ
where k is the retention factor and S is a constant for a
given solute and organic modifier. Using acetonitrile, the
correlation between log k and organic modifier percentage
in the mobile phase is generally appropriately fitted with a
quadratic model:
log k ¼ log kw þ B ϕþ A ϕ2 ð2Þ
where A and B are constant for a given solute and organic
modifier.
Linear correlations between log Poct and log kw obtained
in isocratic conditions have been reported in the literature
with determination coefficients (r2) included in the range
0.81 to 0.99. The best correlations are generally obtained
with analogs or with a low number of analytes [12, 14–16,
19, 25, 26].
Gradient approaches have been developed to accelerate
the procedure of lipophilicity determination. However, one
of the main problems associated with gradient elution
remains the complexity of the involved phenomenon and
associated mathematical treatment. The Linear Solvent
Strength (LSS) Theory elaborated by Snyder and Dolan
[27] allows to express the analyte retention time tR with a
linear-gradient separation in a convenient way:
tR ¼ t0b  log 2:3 ki  bþ 1ð Þ þ t0 þ tD ð3Þ
where ki is the k value in the initial composition of the
gradient, t0 is the column dead time (min) and tD is the
system dwell time for gradient elution (min). The gradient
steepness parameter b can be described by the following
relationship:
b ¼ t0 Δϕ S
tG
ð4Þ
where tG is the gradient time from the beginning to the end
(min) and ∆ϕ the change in composition during the
gradient (ranging from 0 to 1). Eqs. 3 and 4 contain two
unknown terms ki and S, which can be determined by two
chromatographic runs differing only in tG. These two values
then allow to estimate log kw with the help of Eq. 1 when
using methanol as an organic modifier or Eq. 2 with
acetonitrile. Appropriate calculating procedures of the
unknown coefficients are included in several commercially
available software such as Drylab (Rheodyne, CA, USA) or
Osiris (Datalys, Grenoble, France). As in isocratic mode,
numerous linear correlations between log Poct and a
retention property (such as log kw) have been reported in
the literature [12, 14, 17, 19] with r2 generally included in
the range 0.88 to 0.99.
Solvatochromic analysis, an approach based on linear
solvation–energy relationships (LSERs), enables a better
characterization of the stationary phases used for lipophi-
licity determination and can thus lead to an improvement of
correlations in isocratic and gradient modes. This method
was applied to identify and evaluate the intermolecular
forces involved in the partitioning mechanism of compounds
in various organic/aqueous biphasic systems [28–31] and
then extended to chromatography to determine the inter-
molecular forces responsible for the retention on LC
stationary phases [32–35]. LSERs can be expressed by the
following equation:
Sp ¼ n  Vw þ p p*þ a a þ b b þ c ð5Þ
where Sp is a given molecular property of a neutral organic
compound, which can correspond to log Poct or retention
factors (log kw) determined on LC stationary phases. The
four structural terms are the Van der Waals volume Vw, the
dipolarity/polarizability π*, the hydrogen-bond-donor acidity
α and the hydrogen-bond-acceptor basicity β. The regression
coefficients ν, p, a, and b reflect the absolute contribution of
each solute parameter and c is a constant.
Several strategies were successfully applied these last
years to speed up lipophilicity determination by LC such as
the use of shorter columns, higher flow rates, monolithic
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supports, or mass spectrometry detection [36–38]. Short
columns as well as high flow rates decrease the analysis
time and extend the range of measurable log Poct [39–42].
However, these two strategies generate a significant
reduction of the chromatographic performance and accuracy
of the results. Additionally, some overloading problems and
reduced column lifetime have also been reported [43]. With
monolithic supports, a study showed promising results as
analysis time was reduced by a factor ten with results
almost equivalent to those obtained with silica-based
stationary phases [44]. However, the field of application
of these columns remains limited due to the poor resistance
at high pH and the lack of available chemistry at the
moment. Recently, the development of columns packed
with small porous particles (sub-2 μm) has allowed a
significant improvement of chromatographic performance
in LC [45–48]. It is indeed possible to increase the
efficiency by a factor 3 when changing particle size from
5 to 1.7 μm while maintaining an equivalent column length.
The column length can also be drastically reduced
compared to conventional LC to reach high-throughput
separations. For instance, it is possible to decrease analysis
time by a factor 9 when changing particle size from 5 to
1.7 μm while maintaining equivalent efficiencies. However,
a system compatible with very high pressure conditions (up
to 1,000 bar) and possessing a low dead volume is required
to work in such conditions. This strategy is known as ultra-
high-pressure liquid chromatography (UHPLC) and a
suitable chromatographic system was commercialized in
2004 by Waters under the trademark ultra performance
liquid chromatography (UPLC).
In this work, UHPLC coupled with UV or MS detection
was used for log Poct determination. Firstly, several new
silica-based stationary phases packed with 1.7-μm particles
were tested using a well-balanced set of 38 compounds.
Lipophilicity determination was performed with methanol
and acetonitrile as organic modifiers, in both isocratic and
gradient modes to point out their respective advantages and
limitations. This method was then applied to a set of 28
basic pharmaceutical compounds owing to the high stability
of these stationary phases in basic pH conditions, expand-
ing the application field of this approach to basic drugs.




The majority of compounds were obtained from Sigma-
Aldrich (Steinheim, Germany), except 2-chloroaniline
and m-dichlorobenzene from Riedel-de Haën (Seelze,
Germany), ethylacetate from Merck (Dietikon, Switzerland),
metipranolol from Boehringer (Mannheim, Germany), car-
azolol and carvedilol from Roche Diagnostics (Mannheim),
penbutolol from Sanofi-Aventis (Hoechst Marion Roussel,
Paris, France), bupivacaine and mepivacaine from Sintetica
(Mendrisio, Switzerland), lidocaine from Hänseler (Herisau,
Switzerland), and rilmenidine from Servier (Neuilly-sur-
Seine, France). Clonidine, rilmenidine and 5-bromo-N-(4,5-
dihydro-5-methyl-1H-imidazol-2-yl)-6-quinoxalinamine
(Cmp 1) were provided by Professor Pascal Bousquet
(Laboratoire de Neurobiologie et Pharmacologie Cardio-
vasculaire, unité INSERM 715, Faculté de Médecine,
Université Louis Pasteur, Strasbourg, France) and piper-
azines by Professor Serge Labidalle (Laboratoire de
Synthèse, Physico-Chimie et Radiobiologie, Département
de Synthèse Organique, Faculté des Sciences Pharmaceu-
tiques, Université Paul Sabatier, Toulouse, France). Sam-
ples were set at a concentration of 20–100 μg/mL for UV
detection and 2 μg/mL for MS detection. Methanol (10%
to 50%, v/v) was added to enhance compound solubility.
To ensure that the compounds were mostly on their neutral
form, four different buffers with pH values equal to 2.0, 5.0,
9.0, and 10.5 were used depending on the investigated
compound nature (acidic, basic or neutral). The aqueous pH
5.0, 9.0, and 10.5 buffers set at a 20-mM ionic strength were
prepared from acetic acid, ammonium acetate, or ammonia
obtained from Fluka (Buchs, Switzerland). Trifluoroacetic
acid (Fluka) was used to obtain pH 2.0. The buffer
compositions were calculated by the Phoebus software 1.0
(Analis, Namur, Belgium) and the pH value measured with a
Mettler-Toledo Seven-Multi pH meter (Schwerzenbach,
Switzerland). HPLC grade methanol and acetonitrile were
purchased from VWR (Leuven, Belgium), 1-octanol from
Romil (Cambridge, England). Ultra-pure water was supplied
by a Milli-Q Waters Purification System from Millipore
(Bedford, MA, USA).
Apparatus
All retention measurements were performed on a Waters
Acquity UPLC system hyphenated with a UV–VIS pro-
grammable detector possessing a 500 nl flow cell or with a
single quadrupole SQD mass spectrometer possessing an
upper mass limit of m/z 2000 (Milford, MA, USA). This
instrument includes a binary solvent manager with a
delivery flow rate set at 0.5 mL/min, a sample manager
with a 2 μl injection loop (full loop mode) and a column
oven set at 30 °C. Data acquisition, data handling, and
instrument control were performed by Empower 2.0
Software (Waters). UV–VIS wavelength was selected
according to the compound structure to reach maximum
absorbance level. Time constant was always set at 12.5 ms
and data sampling rate at 80 Hz. The ESCi® dual ionization
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source was used in positive ESI mode. All the experiments
were performed in single-ion monitoring (SIM) mode using
a dwell time of 20 ms. The capillary, cone, and source
extractor voltages were set at 3 kV, 30 V, and 2 V,
respectively. The source and desolvation gas temperatures
were maintained at 120 °C and 250 °C, while the
desolvation and cone gas flows were set at 500 and 20 l/
hr, respectively. The four tested columns were Acquity
BEH Shield RP18, Acquity BEH C18, Acquity BEH C8,
and Acquity BEH Phenyl (30 mm×2.1 mm I.D., 1.7 μm)
purchased from Waters.
System characterization: determination of column dead time
Precise knowledge of the column dead time t0 is mandatory
for accurate determination of log k values. Several
approaches summarized in a review by Dorsey et al. were
evaluated, each of them presenting some inherent advan-
tages and limitations [49]. The most accurate methodolo-
gies are clearly the pyconometry or the use of homologous
series but both are time-consuming. An unretained neutral
marker was used to determine t0 as it is a fast, simple, and
non-destructive method. However, it has to be carefully
selected to provide an adequate measure of the dead time.
Uracil, acetone, NaNO3, and D2O were evaluated (data not
shown) and uracil was found to be the most appropriate as
acetone can be retained on a C18 support, NaNO3 presents
Donnan exclusion effects, and D2O is not UV–visible. In
this study, uracil was injected at a concentration of 50 ppm
with a mobile phase composition of 40% acetonitrile/60%
pH 5.0 aqueous buffer. These conditions were selected as a
compromise between low acetonitrile percentages where
uracil could be retained on the support and high percen-
tages detrimental for peak shape.
System characterization: determination of extra-column
volume and delay time
When working with short columns at high-mobile-phase
linear velocities, it is important to apply some corrections to
experimental tR and t0 values to discard the influence of the
chromatographic system and thus obtain accurate log k
values. To fully characterize the chromatographic system,
the elution time of uracil was measured at different flow
rates ranging from 50 to 1,000 μl/min without chromato-
graphic column (replaced by a zero-dead volume union).
The elution times tE were then plotted as a function of 1/
flow-rate (1/F) and a linear regression was performed. The
y-intercept represents the incompressible delay time tdelay
due to the UPLC system and the slope corresponds to the
extra-column dead volume Vext. These two parameters have
to be deduced from t0 and tR measurements. In our UPLC
system, tdelay was equal to 0.010 min (6% of t0 value), Vext
to 16.2 μl in UV detection configuration, and 21.8 μl in
mass-detection configuration (20% and 26% of t0 value at
500 µl/min, respectively). Without considering these two
corrections, t0 values would have been overestimated by
about 30% at 500 μl/min. The influence of tdelay and Vext
was less significant on tR measurements, although still
relevant. Therefore, the following equation was used to
calculate accurate log k values in isocratic mode:
log k ¼ log tR  tdelay  Vext=F
t0  tdelay  Vext=F  1
 
ð6Þ
In gradient mode, corrected tR and t0 values were directly
entered in the modelization software (Eq. 3 and 4).
System characterization: determination of gradient dwell
volume
The system dwell volume or gradient delay volume VD
corresponds to the volume between the mixing point of
solvents and the head of the analytical column. This
parameter is of prime importance and has to be considered
for any modelization in gradient mode because the sample is
prone to an initial isocratic migration. This parameter was
experimentally determined according to a procedure de-
scribed by Dolan [50]. A 5-min gradient of 0.1% acetone in
acetonitrile was performed in triplicate at a flow rate of
0.5 mL/min. The average VD value determined with the 2-μl
injection loop was 100 μl. The latter was considered in Eq. 3.
Procedures
Isocratic mode
Calculations of log k values were performed with tR measure-
ments at five different mobile phase compositions. The
investigated eluent compositions were determined according
to the compound lipophilicity and the nature of the organic
modifier, as summarized in Table 1. Each compound was
injected once with each mobile phase composition and tR
determined from the apex of the peak. The tR measurements
were not repeated because RSD values for triplicate analyses
of model analytes were always lower than 0.2% (data not
shown). Finally, log kw values were obtained by extrapolation
to 0% organic modifier using linear or quadratic relationships
between log k values and methanol or acetonitrile percen-
tages, respectively (Eqs. 1 and 2).
Gradient mode
A generic procedure including two gradients was applied to
modelize the behavior of a compound in the whole organic
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modifier composition range. Gradient profiles were selected
to obtain ke (retention factor of the solute in the eluted
mobile phase composition) equal to 3 and 10. The gradient
slopes were 7.5 and 22.5%/min according to the investi-
gated column geometry and mobile phase flow rate. The
initial and final eluent compositions were set at 2 and 95%
organic modifier, respectively. With tR data obtained from
two gradient runs differing only in gradient time, log kw
values were calculated by solving a set of two equations
equivalent to Eq. 3 and then using Eq. 1. For this purpose,
an iteration procedure included in the HPLC modeling
software Osiris v. 4.1.1.2 was used.
1-octanol addition in isocratic mode
The aqueous buffers were saturated with 1-octanol and a
0.25% (v/v) amount of 1-octanol was added to methanol
[39, 51]. tR measurements as well as log kw calculations
were then performed following the same procedure as for
isocratic measurements using methanol (cf. procedure:
isocratic mode). However, from an experimental point of
view it is recommended to perform tR measurements after a
sufficient equilibration time, beginning the experiments
from the highest to the lowest methanol percentages
according to a previously reported HPLC study (Girod L,
Martel S, and Carrupt PA 2007, Unpublished results).
Results and discussion
Isocratic mode: choice of stationary phase and organic
modifier
As described elsewhere [34], an optimal set of 80
calibration compounds was selected by cluster analysis
from a larger set of 253 compounds according to their Van
der Waals volume (Vw), polarity/polarizability (π*), H-bond
donor acidity (α), H-bond acceptor basicity (β), and log
Poct values. Thirty-eight UV-active compounds of the
optimal set were investigated. They were neutral, acidic
(pKa>3.6) or basic (pKa<5.5) with log Poct values ranging
from 0 to 5 (Table S-1). In isocratic mode, linear relation-
ships between log kw and log Poct values of the 38
calibration compounds were obtained with the four tested
columns using either methanol or acetonitrile, as shown in
Fig. 1. For each tested column and according to the
obtained determination coefficients (r2), better linear rela-
tionships were always achieved with methanol instead of
acetonitrile as the organic modifier. In the literature,
methanol was often regarded as the co-solvent of choice
for measuring log Poct by LC since quadratic extrapolation
(Eq. 2) is less accurate than linear extrapolation (Eq. 1)
[52]. Moreover, methanol is a protic solvent which can
interact with free silanol groups. Therefore, secondary
interactions between analytes and residual silanols can be
reduced and a “pure” hydrophobic retention mechanism
should be observed. During equilibration, methanol forms a
monolayer on the stationary phase, providing a hydrogen
bonding capacity, in better agreement with 1-octanol/water
system [15, 20]. For these reasons, methanol was preferred
to acetonitrile as the organic modifier in this study.
Concerning the stationary phase, the linear relation-
ships with the highest r2 were obtained with the Acquity
BEH Shield RP18 column, containing an embedded
carbamate group. Promising results [15, 53] had already
been obtained in LC with polar-embedded stationary
phases like Supelcosil LC-ABZ+ or Discovery RP Amide
C16 as silanophilic interactions are reduced due to a
“shield” formed over the surface of the silica by the polar-
embedded groups [54]. In this study, linear solvation free-
energy relationships (LSERs) analyses were applied to the
four sets of log kw values and to the set of log Poct values.
These results are reported in Tables S-2 and S-3. The two
main factors governing the retention for the four tested
columns are the Van der Waals volume and H-bond
acceptor basicity, whereas the polarity/polarizability and
H-bond donor acidity are less significant. The Van der
Waals volume and H-bond acceptor basicity are also the
two principal parameters controlling the partitioning in
octanol–water system, which is an additional confirmation
that retention on these stationary phases and partitioning
in biphasic liquid systems are governed by similar
intermolecular forces. By taking into account the 95%
confidence interval, the differences between the Acquity
BEH C18 and Shield RP18 stationary phases are not
significant. Therefore, the Acquity BEH Shield RP18
column was selected for further investigation as it
exhibited the best linear correlations between log kw and
log Poct values and it is characterized by a good
discrimination power.
Using methanol as the organic modifier and the Acquity
BEH Shield RP18 column, the following model between
Table 1 Investigated eluent compositions according to the compound
log Poct and the nature of the organic modifier
Methanol Acetonitrile
log Poct<1 20–60% 10–50%
1<log Poct<2 30–70% 20–60%
2<log Poct<3.5 40–80% 30–70%
3.5<log Poct<4.5 50–80% 40–80%
log Poct>4.5 60–80% 50–80%
Literature log Poct values [64]
Fast log P determination 1923
log Poct and log kw values was derived from the 38
calibration compounds (Fig. 1a):
log kw ¼ 0:83 0:04ð Þ logPoct þ 0:21 0:10ð Þ
n ¼ 38; q2 ¼ 0:98; r2 ¼ 0:98; s ¼ 0:12;F ¼ 2052
ð7Þ
In this and following equations, n is the number of
compounds, q2 the cross-validated correlation coefficient,
r2 the determination coefficient, s the standard deviation, F
the Fisher coefficient, and 95% confidence intervals are
given in parentheses.
























































































r2 = 0.98 r2 = 0.96
r2 = 0.96 r2 = 0.95
r2 = 0.95 r2 = 0.94
r2 = 0.93 r2 = 0.91
slope = 0.83 ± 0.04 slope = 0.87 ± 0.06
slope = 0.72 ± 0.05 slope = 0.71 ± 0.06
slope = 0.79 ± 0.06 slope = 0.79 ± 0.07





Fig. 1 Relationship between
log kw and log Poct for the 38
calibration compounds in
isocratic mode using methanol
as the organic modifier and the
Acquity BEH Shield (a), C18
(b), C8 (c) or Phenyl (d) col-
umns, respectively. (e–h): idem,
using acetonitrile as the organic
modifier
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Gradient mode
In gradient mode, a good linear relationship between log kw
and log Poct values of the 38 calibration compounds was
obtained as previously demonstrated in a preliminary work
involving UHPLC technology [55]:
log kw ¼ 0:84 0:07ð Þ logPoct þ 0:31 0:22ð Þ
n ¼ 38; q2 ¼ 0:95; r2 ¼ 0:95; s ¼ 0:21;F ¼ 742 ð8Þ
To carefully compare the isocratic and gradient modes, many
parameters have to be considered (Table 2). Firstly, the log
kw–log Poct linear correlation is better in isocratic mode
(Eq. 7) than in gradient mode (Eq. 8) in terms of r2 (0.98
versus 0.95) and standard deviation (0.1 versus 0.2).
Secondly, the average log Poct determination time is similar
in both modes (around 25 and 20 min/compound in isocratic
and gradient mode, respectively). However, the approach is
compound-dependent in isocratic mode as appropriate
mobile phase compositions and run times have to be
determined for each investigated compound (see procedure:
isocratic mode) while it is generic in gradient mode. Finally,
sensitivity might be an issue in isocratic mode as there is a
serious decrease in peak height for compounds eluted with
high retention factors, due to band broadening inside the
column. In gradient mode, this problem is not observed since
the peak width is almost constant whatever the retention time
of the compound. In conclusion, the isocratic mode should
be preferred to the gradient one in terms of trueness while
the gradient approach is generic and thus far more suitable
for high-throughput log Poct measurements.
Assessment of the procedure with a set of basic
pharmaceutical compounds
The chemical resistance of stationary phases such as the
Acquity BEH Shield RP18 column in high pH conditions
(up to pH 11) is a very interesting feature as classical silica-
based stationary phases are only stable within a limited pH
range (pH 2-8). These hybrid stationary phases with
hydrophobic ethylene groups present throughout the parti-
cle backbone are believed to shield the silica units and
prevent them from dissolution. Besides this hydrophobic
shielding, the structural ethylene bridges increase the
hydrolytic stability of the particles [56]. This stationary
phase is thus well suited for log Poct estimation of basic
compounds in high pH conditions.
To take advantage of this chemical stability, 28 basic
compounds with pKa values ranging from 6.3 to 9.6 were
selected and the quality of the relationship between log Poct
and log kw evaluated in a similar way to the 38 calibration
compounds. As shown in Fig. 2, basic drugs have a
different behavior from the calibration compounds in both
isocratic and gradient modes. Basic compounds are gener-
ally more retained on the stationary phase though the
phenomenon seems family-dependent. For example, cloni-
dine and derivatives have the same retention characteristics
as calibration compounds while beta-blockers and local
anesthetics behave in a much different way from all the
other basic analytes. In the literature [20, 57–61] this
increase in retention was usually attributed to silanophilic
interactions due to the remaining free silanol sites, which
can include hydrogen bonding, dipole interactions as well
as electrostatic forces (ion exchange) [62].
At this point, it is necessary to consider the effect of the
organic modifier on pKa values of the buffer, the acidic
silanol groups, and the solutes [53, 63]. For example, the
apparent mobile phase pH varied according to the organic
modifier percentage. For experiments with basic com-
pounds, the aqueous buffer pH was 10.54, whereas the
s
wpH of the buffer in 40% and 70% methanol was 10.18 and
9.98, respectively. This might for instance influence the
ionization state of the silanol groups on Acquity BEH








0.1 0.2 0.1 0.1
Standard deviatione (basic compounds) 0.4f 0.4f 0.2 0.2
Average log Poct determination
time (min)
25′ 20′ 25′ 5′
Approach Compound-dependent Generic Compound-dependent Generic
a log Poct determined by UHPLC-UV in isocratic mode by extrapolation to 100% water (Eq. 7)
b log Poct determined by UHPLC-UV in gradient mode by extrapolation to 100% water (Eq. 8)
c log Poct determined by UHPLC-UV in isocratic mode with 1-octanol addition by extrapolation to 100% water (Eq. 10)
d log Poct determined by UHPLC-UV with a single measurement at 50% methanol (Eq. 9)
e Standard deviation calculated from the difference between literature log Poct and log PUHPLC with n=38 (calibration compounds) or n=28
(basic compounds)
f Aside from the high standard deviation, there is also a systematic bias for numerous basic compounds (Fig. 2)
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columns as their acidity is low (pKa>8) [56]. In addition,
the ionization states of the most deviating basic compounds
(beta-blockers and local anesthetics) were measured at
different mobile phase compositions by capillary electro-
phoresis using a methodology detailed in the supporting
information. Results are reported in Fig. S-1. From these
measurements it can be concluded that beta-blockers were
not completely in their neutral form (except carvedilol):
there was about 10% of ionized form at each tested mobile
phase composition, while local anesthetics were almost
completely on their neutral form (except butacaine). Thus,
the particular behavior of beta-blockers and local anes-
thetics seems not due to the percentage of ionized form and
to electrostatic interactions with free silanol groups.
However, it does not exclude hydrogen bonding, according
to LSERs analyses (Tables S-2 and S-3). Indeed, silano-
philic interactions can be present despite the carbamate-
embedded group, which is usually considered to reduce
such effects due to electrostatical shielding [20]. By
comparing these results with those obtained on an Acquity
BEH C18 column (data not shown), it can be concluded
that the polar-embedded groups might prevent ionic
interactions with free silanol groups but not hydrogen
bonding with the stationary phase.
The effects of the organic modifier are significant and
depend on its proportion in the mobile phase. When log
kw values are extrapolated from different organic modifier
concentration ranges (depending on the lipophilicity of the






















a bFig. 2 Relationship between logkw and log Poct for the 28 basic
compounds in isocratic (a) and
gradient mode (b): beta-blockers
(filled upright triangles), local
anesthetics (filled inverse trian-
gles), piperazines (empty circles)
and clonidine + derivatives
(asterisks). The black straight
line is the linear regression for the
38 calibration compounds


















































Fig. 3 Relationship between isocratic log k values and log Poct for the
28 basic compounds: beta-blockers (filled upright triangles), local
anesthetics (filled inverse triangles), piperazines (empty circles) and
clonidine + derivatives (asterisks). Methanol percentage: 40% (a),
50% (b), 60% (c), and 70% (d). The black straight line is the linear
regression for the 38 calibration compounds
1926 Y. Henchoz et al.
investigated compounds), such effects are not taken into
account. Therefore, correlations between log Poct and
isocratic log k values were explored, as depicted in Fig. 3.
Indeed, the 28 basic compounds seem to have a similar
behavior to the calibration set at 50% of methanol, as the
linear correlation between log k50% and log Poct presents the
lowest dispersion (r2 0.95 including both the calibration and
basic compounds sets). Moreover, the retention factors of
compounds with 0<log Poct<5 were acceptable at 50%
methanol. Concerning the slope (i.e., discrimination power),
the lowest percentage of methanol provided the highest
slope. However, log k50% presents the best compromise
between low dispersion, suitable analysis time, and high
discrimination power.
The following model between log Poct and log k50%
values was derived from the 38 calibration compounds:
log k50% ¼ 0:52 0:02ð Þ logPoct  0:56 0:05ð Þ
n ¼ 38; q2 ¼ 0:98; r2 ¼ 0:98; s ¼ 0:08;F ¼ 2048 ð9Þ
This equation enabled to calculate log Poct values for the 28
investigated basic compounds. The obtained results are
reported in Table 3 and demonstrate that a single analysis at
50% methanol allows an acceptable log Poct estimation for
basic compounds with a low standard deviation (0.2;
Table 3 Data obtained for the 28 basic compounds




Pindolol 9.54d 1.8d 1.9 1.9 1.9
Metoprolol 9.63d 2.0d 2.2 2.2 2.2
Acebutolol 9.52d 2.0d 2.0 1.9 1.9
Bisoprolol 9.57d 2.2d 2.6 2.6 2.6
Oxprenolol 9.57d 2.5d 2.6 2.5 2.6
Metipranolol 9.54d 2.8d 3.0 2.9 2.9
Alprenolol 9.59d 3.1d 3.4 3.3 3.4
Propranolol 9.53d 3.5d 3.4 3.3 3.4
Carazolol 9.52d 3.7d 3.3 3.3 3.3
Carvedilol 7.97d 4.1d 3.9 3.8 3.9
Mepivacaine 7.72e 1.9f 2.2 2.2 2.2
Procaine 8.95e 2.0f 2.1 2.1 2.1
Prilocaine 7.84e 2.1f 2.3 2.3 2.3
Lidocaine 7.82e 2.3f 2.9 2.8 2.8
Tetracaine 8.35e 3.4f 3.6 3.6 3.7
Bupivacaine 8.06e 3.7f 3.7 3.7 3.8
Dibucaine 8.61e 4.2f 4.3 4.3 4.4
Butacaine 9.51e 4.3f 4.7 4.6 4.7
Cmp 1 7.78f 1.4f 0.7 0.8 0.8
Clonidine 8.11f 1.6f 1.4 1.4 1.5
Rilmenidine 9.23f 1.6f 1.7 1.8 1.8
SPLV 1058-2 9.05f 1.1f 1.4 1.4 1.4
SPLV 1058-1 8.73f 1.2f 1.3 1.4 1.3
SPLV 1058-9 8.33f 1.9f 2.1 2.1 2.1
SPNL 2075-1 8.36f 2.5f 2.8 2.7 2.7
SPLV 1058-5 6.26f 2.6f 2.7 2.7 2.7
SPLV 1077 7.60f 3.4f 4.2 4.1 4.2
SPLV 1058-7 8.41f 3.7f 4.0 4.0 4.0
a log Poct determined by UHPLC-UV with a single measurement at 50% methanol (Eq. 9); standard deviation 0.2 (Table 2)
b log Poct determined by UHPLC-MS with a single measurement at 50% methanol (Eq. 9); standard deviation 0.2
c log Poct determined by UHPLC-UV in isocratic mode with 1-octanol addition by extrapolation to 100% water (Eq. 10); standard deviation
0.2 (Table 2)
d Determined by potentiometry [65]
eMeasured by capillary electrophoresis according to a method described elsewhere [66]
f Determined by potentiometry
Fast log P determination 1927
Table 2). The precision of this determination is comparable
to the precision of other experimental methods used for log
Poct measurement. Furthermore, this strategy is rapid as the
average log Poct estimation time is only 5 minutes per
compound. Such approaches were previously reported in
the literature and similar conclusions were drawn in
conventional LC [37, 53].
Alternatively, the well-known approach described by
Lombardo et al. [39, 51] was tested for log Poct
determination of the 38 calibration compounds and 28
basic drugs. In this method, 0.25% (V/V) 1-octanol was
added to methanol and buffers were saturated with 1-
octanol. Under these conditions, the 28 basic drugs have a
similar behavior to calibration compounds, as depicted in
Fig. 4. Indeed, a good linear relationship is obtained
between extrapolated log kw and log Poct values for
calibration and basic compounds (r2 0.96), thus allowing
the derivation of the following equation for the 38
calibration compounds:
logkw¼ 0:95 0:04ð ÞlogPoct0:24 0:11ð Þ
n ¼ 38; q2¼ 0:98; r2¼ 0:98; s ¼ 0:13; F ¼ 2216 ð10Þ
The log Poct values of the 28 investigated basic com-
pounds could be calculated with Eq. 10. The results are
reported in Table 3 and demonstrate that extrapolated log
kw values measured in isocratic mode using 1-octanol as a
mobile phase additive also allow a good log Poct
estimation for basic compounds with a low standard
deviation (0.2) (Table 2). Moreover, the slope in Eq. 10
is higher than in Eq. 7–9, indicating a high discrimination
power. It is also very close to unity, meaning that the
retention process is energetically similar to the partitioning
process in a 1-octanol/water system. In addition, LSERs
analyses show that retention on the Acquity BEH Shield
RP18 column with 1-octanol addition in the mobile phase
and partitioning in biphasic liquid systems are similar
phenomena (Tables S-2 and S-3). In fact, 1-octanol seems
to form a coating on the silica support of the column
during equilibration, conferring octanol-like properties to
the stationary phase. These results prove that this method
is an alternative to the log k50% approach to determine log
Poct of basic compounds. However, the log k50% approach
is more generic and rapid with a log Poct determination
time of 5 minutes. It should thus be preferred to the
method proposed by Lombardo for high-throughput log
Poct measurements.
Increased throughput with MS detection
The potential of UHPLC hyphenated to MS detection
was investigated to further increase the throughput of log
Poct estimation. Indeed, due to the additional selectivity of
MS instrument, several compounds can be analyzed
simultaneously.
Generic MS conditions were found for log Poct estima-
tion of the 28 basic compounds at 50% methanol. 8-10
compounds were simultaneously analyzed to maintain an
acceptable acquisition rate and allow a straightforward MS
discrimination with the single quadrupole analyzer. If the
molecular mass information is not available, this approach
is perfectly compatible with SCAN mode determination.
The log Poct calculated with Eq. 10 are consistent with
those obtained with UV detection, as reported in Table 3.
The slight differences observed are probably due to small
uncertainties of extra-column volume determination in UV
and MS configurations. Another advantage of the UHPLC-
MS strategy is the number of log Poct determination that
could be performed on a given column at pH 10.5. Finally,
the UHPLC-MS approach allows high-throughput measure-
ments since log Poct of 8-10 compounds can be estimated in
only 5 minutes.
Conclusion
Four approaches were tested for log Poct determination by
UHPLC, as summarized in Table 2. Firstly, suitable
conditions in terms of stationary phase (Acquity BEH
Shield RP18) and organic modifier (methanol) were found
by correlation with log kw values in the isocratic mode. This
method is accurate for neutral, acidic (pKa>3.6) and weak
basic (pKa<5.5) compounds but a systematic bias was
observed when dealing with relatively basic (pKa>6.3)
compounds. Moreover, this strategy is not generic enough
for high-throughput measurements.
Lipophilicity was also determined by correlation with
log kw values in gradient mode, which is a generic approach
compatible with high-throughput measurements. However,
this method is not suitable to relatively basic compounds











Fig. 4 Relationship between log kw values obtained with 1-octanol as
a mobile phase additive and log Poct for the 28 basic compounds: beta-
blockers (filled upright triangles), local anesthetics (filled inverse
triangles), piperazines (empty circles) and clonidine + derivatives
(asterisks). The black straight line is the linear regression for the 38
calibration compounds
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and not as good as the isocratic mode in terms of trueness.
Moreover, data treatment remains complex.
The determination of log Poct values by correlation with
log kw values in isocratic mode with 1-octanol addition
allows an accurate log Poct measurement for all tested
compounds, including relatively basic compounds. Never-
theless, this strategy remains tedious and time-consuming
(cf. 1-octanol saturation of aqueous phases and equilibra-
tion of UHPLC system).
The determination of log Poct with a single analysis at
50% methanol turns out to be the method of choice as it is a
generic, rapid (ca 5 minutes per compound) and accurate
for all investigated compounds. Finally, the MS coupling
allows more rapid lipophilicity determination (ca 5 minutes
per 10 compounds).
In conclusion, the two most important features of the
UHPLC approach for lipophilicity measurements are its
high throughput (one compound per 5 min with UV
detection and ten compounds per 5 min with MS detection)
and its applicability to basic compounds due to the stability
of the hybrid stationary phase at high pH values.
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